郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Synthesis and Characterization of Azido Aryl Analogs of IBNtxA for Radio-Photoaffinity Labeling Opioid Receptors in Cell Lines and in Mouse Brain.

期刊：Cellular and molecular neurobiology发表年份：2021作者：Steven G Grinnell; Rajendra Uprety; Andras Varadi; Joan Subrath; Amanda Hunkele; Ying Xian Pan; Gavril W Pasternak; Susruta Majumdar
阅读更多 →

药效评价Novel serotonin 5-HT2A receptor antagonists derived from 4-phenylcyclohexane-5-spiro-and 5-methyl-5-phenyl-hydantoin, for use as potential antiplatelet agents.

期刊：Pharmacological reports : PR发表年份：2021作者：Anna Czopek; Monika Kubacka; Adam Bucki; Agata Siwek; Barbara Filipek; Maciej Pawłowski; Marcin Kołaczkowski
阅读更多 →

药效评价BK channel activation by L-type Ca2+ channels CaV1.2 and CaV1.3 during the subthreshold phase of an action potential.

期刊：Journal of neurophysiology发表年份：2021作者：Amber E Plante; Joshua P Whitt; Andrea L Meredith
阅读更多 →

药效评价Neuropharmacological and antidepressant-like effects of ZY-1408: A novel serotonin/norepinephrine reuptake inhibitor and serotonin receptor 2C antagonist.

期刊：Neuropharmacology发表年份：2021作者：Nana Gao; Murezati Tiliwaerde; Wei Zheng; Jie Xiong; Xiaorong Li; Zengliang Jin
阅读更多 →